Loading…
* Free cash flow = OCF − net investing outflow (the filings carry no standalone capex line).
Dividends declared (per SOCE filings): FY2022 0 · FY2023 3,800 · FY2024 0 — 3-yr total 3,800
Operates in Healthcare Services — In-patient & out-patient services. Per the activity note to the FY2024 annual report, the company provides medical services including emergency care, ambulatory and in-patient treatment, neurology and intervention services. Founded 1979. Located in Saburtalo, Al. Kazbegi Avenue, 16, Tbilisi.
Subsidiary of Aversi-Pharma (100.0%)
| Line item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | CAGR |
|---|---|---|---|---|---|---|---|---|---|
| 2,706 | 6,637 | 9,164 | 10,336 | 14,979 | 11,578 | 6,471 | 8,973 | +18.7% | |
| 10,766 | 11,369 | 14,340 | 13,868 | 15,413 | 14,138 | 14,218 | 13,574 | +3.4% | |
| TOTAL ASSETS | 13,472 | 18,006 | 23,504 | 24,205 | 30,392 | 25,717 | 20,689 | 22,547 | +7.6% |
| 2,177 | 4,992 | 4,427 | 3,587 | 3,835 | 1,835 | 3,036 | 2,735 | +3.3% | |
| 100 | 0 | 3,592 | 3,412 | 3,436 | 3,237 | 2,903 | 2,635 | +59.7% | |
| TOTAL LIABILITIES | 2,277 | 4,992 | 8,019 | 6,998 | 7,270 | 5,072 | 5,938 | 5,370 | +13.0% |
| 11,195 | 13,013 | 15,485 | 17,207 | 23,121 | 20,644 | 14,751 | 17,177 | +6.3% | |
| Balance Check (Assets - L&E) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Debt analysis | |||||||||
| Total Debt | 100 | 0 | 4,655 | 3,592 | 3,650 | 3,436 | 3,196 | 2,981 | +62.5% |
| Cash & Equivalents | 328 | 331 | 671 | 361 | 234 | 3,961 | 258 | 2,134 | +30.7% |
| Net Debt | 228 | 331 | 3,984 | 3,232 | 3,416 | 526 | 2,938 | 846 | nmf |
Shareholders, directors and group links from the companyinfo.ge public register — as filed, so stakes need not sum to 100% where a holding is undisclosed.
Ownership & directors from companyinfo.ge (public corporate registry).
Ranked by how close each latest revenue is to this one — not a curated comp set. Open this set in Compare →